When Joani Reisen said he health insurance suddenly cut off coverage for her critical medication, she turned to an unlikely ...

Zydus Lifesciences’ subsidiary ZyVet Animal Health has launched FDA-approved generics for urinary incontinence ...

Teva Pharmaceuticals can pursue most of its lawsuit accusing rival drugmaker Corcept Therapeutics of monopolizing the market ...

Biocon CEO Siddharth Mittal reveals plans to launch generic versions of diabetes drug Ozempic in key markets by the end of ...

The $5.7 billion Indian drug maker is building capacity to tap into the massive opportunity from GLP-1 drugs to open up in ...

The real question is how to re-shore pharmaceutical production while minimizing the costs to patients, economist Tomas J.